Current Law Journal Content
Washington & Lee Law School
  Current Law Journal Content
                  an index to legal periodicals
 


  Biotechnology Law Report
  Volume 29, Number 1, February 2010
  homepage                   other issues
 

  • OBITUARY
  • Albert P. Halluin (1939–2010)
        Harold C. Wegner
        p.1                                                                                          +cite        

  • ARTICLE
  • Plugging the GATTS and WTOs: Toward a Globalized Pharmaceutical Regulatory Framework
        E.M. Abler
        p.3-16                                                                                    +cite        

  • COMMENTS ON RECENT CASES
  • Selection Patents and Markush Claims in Europe
        Robert Fitt
        p.17-20                                                                                  +cite        
  • Comments on U.S. Developments
        Harold C. Wegner
        p.21-22                                                                                  +cite        
  • Getting Beyond the ACLU and Public Patent Foundation's Anti-Gene-Patent Grandstanding
        Scott Rylan Powell, Gerry J. Elman
        p.23-27                                                                                  +cite        

  • HEARING REPORT
  • ACLU Lawyers Face Off Against the U.S. Patent Office and Myriad Genetics
        Scott Rylan Powell, Gerry J. Elman
        p.29-31                                                                                  +cite        

  • REGULATORY AFFAIRS—PHARMACEUTICAL
  • Transparency Initiative Launched; FDA Describes What It Does; Genzyme Resumes Product Shipments; FDA to Take Another Look at Epo; New Type of Biologic Approved for Rheumatoid Arthritis; More Information to Be Available on Tysabri Complication; Nanotechnology Safety Act Introduced in Congress; Problems with GINA?; Anti-Bioterror Efforts Found Wanting; Teva Files for Biosimilar Filgrastim; When Can a Company Not Be Fined for Off-Label Promotion?; FDA Should Add Safety Symbol to Web Sites for Prescription Drugs; How Is Human DNA Used in Animals?
        p.33-37                                                                                  +cite    

  • CLINICAL TRIALS
  • Genetic-Specific Drug for CML Fails to Impress FDA; FDA Guidance on Continuing IRB Review
        p.39-40                                                                                  +cite    

  • REGULATORY AFFAIRS—AGRICULTURAL AND ENVIRONMENTAL
  • Supreme Court Agrees to Hear Alfalfa Case
        p.41                                                                                        +cite    

  • PATENTS
  • Final Rules on Ex Parte Appeals?; U.S., India Sign Patent Agreements; Trying to Avoid Issuance of Patents on Traditional Knowledge; The PTO Goofed; Patent Term Extensions Granted by Office Revised by CAFC; Work of Two British Scientists Asserted Against Amgen Patent; WARF Criticizes Suggestion That Genetic Tests Should Not Be Patentable; Thermal Cycler Patent Revoked; BLR Archives: Interference Decision on Fluid Mixing for Microarrays Overturned
        p.43-49                                                                                  +cite    

  • PATENT AND TRADE SECRET LITIGATION
  • Neutrokine-α Technology Has No Industrial Utility; Perlan's Identification of Trade Secrets Inadequate to Permit Discovery; Mass Spectrometry Patents Said to Be Infringed; Teva's ANDA Said to Infringe Bivalirudin Patent; Illumina Countersues for Infringement of Genetic Analysis Technology
        p.51-55                                                                                  +cite    

  • FINANCIAL AND SHAREHOLDER AFFAIRS
  • DoJ Investigating Sales of Roundup Ready Soybeans
        p.57                                                                                        +cite    

  • LICENSING AND COLLABORATIONS
  • WARF Retains Anti-Cholesterol Compound IP
        p.59-60                                                                                  +cite    
  • On The Move
        p.61                                                                                        +cite    

  • DOCUMENTS
  • Guidance: IRB Continuing Review After Clinical Investigation Approval (excerpts)
        p.63-70                                                                                  +cite    
  • Amicus Curiae Brief of Washington Legal Foundation in Monsanto Co., et al. v. Geertson Seed Farms, et al.
        p.71-75                                                                                  +cite    
  • Rules of Practice Before the Board of Patent Appeals and Interferences in Ex Parte Appeals; Request for Comments on Potential Modifications to Final Rule and Notice of Roundtable During Comment Period
        p.77-93                                                                                  +cite    
  • Wyeth and Elan Pharma International Ltd. v. David J. Kappos, Director of the United States Patent and Trademark Office (2009-1120)
        p.95-99                                                                                  +cite    
  • Agilent Technologies, Inc. v. Affymetrix, Inc. (2008-1466)
        p.101-112                                                                              +cite    
  • Perlan Therapeutics, Inc. v. The Superior Court of San Diego County and NexBio, Inc., et al., Real Parties in Interest (Super. Ct. No. GIC871276)
        p.113-123                                                                              +cite    
  • Before: The Rt. Hon. Lord Justice Jacob, The Rt. Hon. Lady Justice Hallett, and The Hon. Mr. Justice Lewison; Between: Eli Lilly and Company and Human Genome Sciences, Inc. (excerpts)
        p.125-131                                                                              +cite    
  • Wisconsin Alumni Research Foundation v. Xenon Pharmaceuticals, Inc. (Nos. 08-1351 & 06-3901)
        p.133-141                                                                              +cite    
  • Coming Events
        p.143-145                                                                              +cite